Catalyst Wire Dossier Catalyst Wire Dossier

NANT Urothelial Cancer Vaccine

NANT urothelial cancer vaccine · ImmunityBio, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NANT Urothelial Cancer Vaccine, covering 2025-02-21 to 2025-02-21. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy [Phase 1, Phase 2]

See pricing